Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 3977194)

1.

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.

Michiels JJ, Abels J, Steketee J, van Vliet HH, Vuzevski VD.

Ann Intern Med. 1985 Apr;102(4):466-71.

PMID:
3977194
3.

Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.

Michiels JJ, van Genderen PJ, Lindemans J, van Vliet HH.

Leuk Lymphoma. 1996 Sep;22 Suppl 1:47-56. Review.

PMID:
8951772
4.

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.

Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, van Vliet HH.

Blood Cells Mol Dis. 2006 Mar-Apr;36(2):199-205. Epub 2006 Feb 28. Review.

PMID:
16510297
5.

Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.

Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.

Semin Thromb Hemost. 2006 Apr;32(3):174-207. Review.

PMID:
16673274
6.
7.
8.

Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.

Tarach JS, Nowicka-Tarach BM, Matuszek B, Nowakowski A.

Med Sci Monit. 2000 Jan-Feb;6(1):204-8. Review.

9.

Erythromelalgia and vascular complications in polycythemia vera.

Michiels JJ.

Semin Thromb Hemost. 1997;23(5):441-54. Review.

PMID:
9387203
10.
11.
12.

The risk of thrombosis in essential thrombocythemia and polycythemia vera.

Pearson TC.

Semin Oncol. 2002 Jun;29(3 Suppl 10):16-21. Review.

PMID:
12096353
13.

Therapeutic options for essential thrombocythemia and polycythemia vera.

Solberg LA Jr.

Semin Oncol. 2002 Jun;29(3 Suppl 10):10-5. Review.

PMID:
12096352
14.

Atypical transient ischemic attacks in thrombocythemia of various myeloproliferative disorders.

Michiels JJ, van Genderen PJ, Jansen PH, Koudstaal PJ.

Leuk Lymphoma. 1996 Sep;22 Suppl 1:65-70. Review.

PMID:
8951774
15.

[When should a myeloproliferative syndrome be suggested in vascular medicine?].

Lazareth I, Delarue R, Priollet P.

J Mal Vasc. 2005 Feb;30(1):46-52. Review. French.

PMID:
15924069
16.
17.

Erythromelalgia and myeloproliferative disorders.

Kurzrock R, Cohen PR.

Arch Intern Med. 1989 Jan;149(1):105-9. Review.

PMID:
2643412
18.

[What vascular events suggest a myeloproliferative disorder?].

Hachulla E, Rose C, Trillot N, Caulier-Leleu MT, Pasturel-Michon U.

J Mal Vasc. 2000 Dec;25(5):382-387. Review. French.

PMID:
11148402
20.

Erythromelalgia: diagnosis and classification.

Norton JV, Zager E, Grady JF.

J Foot Ankle Surg. 1999 May-Jun;38(3):238-41. Review.

PMID:
10384366
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk